4//SEC Filing
David Christopher Mehlin 4
Accession 0001493152-23-019954
CIK 0001138978other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:05 PM ET
Size
6.3 KB
Accession
0001493152-23-019954
Insider Transaction Report
Form 4
David Christopher Mehlin
DirectorPresident
Transactions
- Award
Stock Option (right to buy)
2023-05-31+2,000,000→ 2,000,000 totalExercise: $0.13From: 2023-05-31Exp: 2029-05-31→ Common Stock (2,000,000 underlying)
Holdings
- 81,950
Class A Common Stock
Footnotes (1)
- [F1]Represents the grant, by the issuer's Board of Directors, of an option to purchase 2,000,000 shares of the issuer's common stock at an exercise price of $0.132 per share. The option was fully vested and exercisable on the date of grant and expires on May 31, 2029.
Documents
Issuer
Novo Integrated Sciences, Inc.
CIK 0001138978
Entity typeother
Related Parties
1- filerCIK 0001846842
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:05 PM ET
- Size
- 6.3 KB